MUMBAI, India, May 16 -- Intellectual Property India has published a patent application (202517022846 A) filed by Takeda Pharmaceutical Company Limited, Osaka, Japan, on March 13, for 'composition for use in the treatment of fabry disease.'
Inventor(s) include Islam, Rizwana; Ruangsiriluk, Wanida; and Deshpande, Mugdha, Ravindra.
The application for the patent was published on May 16, under issue no. 20/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure provides, among other things, gene therapy approaches of treating Fabry disease in a subject, particularly for alleviating periphery neuropathy associated with Fabry disease. The method comprises administering to a subject in need thereof ...